Compare Amphastar Pharmaceuticals Inc (AMPH) vs Google Inc (GOOG) Price & Performance

AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.

Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.

Alphabet (GOOG) trades at $353.47, down 0.88% today, with a bullish technical outlook supported by moving averages and strong support at $352. The company shows robust fundamentals, with 2025 revenue of $402.84B and net income of $132.17B, alongside consecutive earnings beats in recent quarters. Recent news highlights aggressive AI investments and cloud growth, while analyst sentiment remains overwhelmingly positive.

The outlook for GOOG is favorable, driven by AI expansion and cloud revenue growth, with a consensus price target of $431.67 implying significant upside. Risks include high capital expenditures, competitive pressures, and regulatory scrutiny, but strong cash flow and profitability metrics support a bullish investment case for long-term investors.